The Covid-19 Early Treatment Fund was launched to provide funding for research in order to "find an existing drug or drug combination that, when given early, reduces hospitalization…
In an interview for NBC News, Vin Gupta, MD, MPA, MSc, affiliate assistant professor of Health Metrics Sciences at the Institute for Health Metrics and Evaluation (IHME) at…
NEW YORK (Reuters Health) – Thrombolysis is a must for female stroke patients if they are to achieve the same outcomes as men, according to a March 2nd…
NEW YORK (Reuters Health) – Pregnant women who’ve had abnormal cervical tissue removed with a loop electrosurgical procedure (LEEP) are not at increased risk for preterm delivery, a…
NEW YORK (Reuters Health) – Interim data from a 3-year trial of stenting versus endarterectomy for symptomatic carotid stenosis suggests that for now at least, surgery should remain…
NEW YORK (Reuters Health) – Patients with aortoiliac peripheral arterial disease (PAD) have worse event-free survival than patients with more distal PAD, according to a report in the…
NEW YORK (Reuters Health) – Beta blockade before computed tomographic coronary angiography (CTA) can improve image quality, but a substantial number of patients who require CTA have contraindications…
Gary Small, MD, Director, UCLA Center on Aging, UCLA, discusses brain health and the impact that lifestyle factors have over genetics on brain health, and in particular, diet,…
David Heber, MD, Professor of Medicine, Director, UCLA Center for Human Nutrition, discusses nutrition in breast cancer, and the role of diabetes and obesity in post-menopausal breast cancer,…
Andrew Charles, MD, Professor, Director of Headache Research and Treatment Program, UCLA David Geffen School of Medicine, discusses migraine diagnosis and diagnostic criteria that focus on associated symptoms…
NEW YORK (Reuters Health) – Superficial venous thrombosis is often considered benign, but new research suggests that one in four patients also have deep venous thrombosis (DVT) or…
NEW YORK (Reuters Health) – In treating acute coronary syndromes, a slow response to clopidogrel in the first hour of administration predicts a low response at 24 hours…
